These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16138507)

  • 1. Preventing contrast-induced nephropathy: a basic solution.
    Bridges JM; Feldstein DA
    WMJ; 2005 Jul; 104(5):9-10. PubMed ID: 16138507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
    Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
    Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
    Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
    Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
    Masuda M; Yamada T; Mine T; Morita T; Tamaki S; Tsukamoto Y; Okuda K; Iwasaki Y; Hori M; Fukunami M
    Am J Cardiol; 2007 Sep; 100(5):781-6. PubMed ID: 17719320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Maioli M; Toso A; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Bellandi F
    J Am Coll Cardiol; 2008 Aug; 52(8):599-604. PubMed ID: 18702961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
    Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
    J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New usage for an old drug: acetylcysteine for contrast-induced nephropathy].
    Asher I; Hammerman A; Sthoeger Z
    Harefuah; 2005 Sep; 144(9):642-6; 675. PubMed ID: 16218537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical inquiries. What interventions reduce the risk of contrast nephropathy for high-risk patients?
    Grossman PD; Burroughs M; Guthmann RA
    J Fam Pract; 2005 Apr; 54(4):365-7. PubMed ID: 15833230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of contrast-induced nephropathy: the rational use of sodium bicarbonate.
    Barreto R
    Nephrol Nurs J; 2007; 34(4):417-21. PubMed ID: 17891910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcysteine to prevent acute contrast-induced nephropathy.
    Mears JM
    Am Fam Physician; 2004 Dec; 70(11):2077; author reply 2077. PubMed ID: 15606054
    [No Abstract]   [Full Text] [Related]  

  • 11. Sodium bicarbonate versus normal saline for protection against contrast nephropathy.
    Budhiraja P; Chen Z; Popovtzer M
    Ren Fail; 2009; 31(2):118-23. PubMed ID: 19212908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast medium-induced nephropathy: strategies for prevention.
    Massicotte A
    Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen].
    Huisman IA; Stegeman CA; Gans RO; Gansevoort RT
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2329-33. PubMed ID: 16261711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen].
    Kramers C; Wetzels J; Natsch S; ten Dam M
    Ned Tijdschr Geneeskd; 2006 Feb; 150(5):274; author reply 275-6. PubMed ID: 16493996
    [No Abstract]   [Full Text] [Related]  

  • 15. Contrast-induced nephropathy: a review.
    Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
    Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of contrast-induced nephropathy by use of bicarbonate solution: preliminary results and literature review.
    Silva RG; Silva NG; Lucchesi F; Burdmann EA
    J Bras Nefrol; 2010; 32(3):292-302. PubMed ID: 21103694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing contrast nephropathy: what is the best strategy? A review of the literature.
    Cox CD; Tsikouris JP
    J Clin Pharmacol; 2004 Apr; 44(4):327-37. PubMed ID: 15051739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
    Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
    Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics.
    Coyle LC; Rodriguez A; Jeschke RE; Simon-Lee A; Abbott KC; Taylor AJ
    Am Heart J; 2006 May; 151(5):1032.e9-12. PubMed ID: 16644332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease.
    Klarenbach SW; Pannu N; Tonelli MA; Manns BJ
    Crit Care Med; 2006 Apr; 34(4):1044-51. PubMed ID: 16484907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.